Atlas Trials

Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138

Clinical trial NCT01886976 · UNKNOWN

Trial details

NCT number
NCT01886976
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2013-06-01
Primary completion
2016-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.